CVRS News and Press, Corindus Vascular Robotics Inc. (DE) From 08/08/19

Corindus Vascular Robotics (NYSEMKT: CVRS ): Q2 GAAP EPS of -$0.06 misses by $0.02 . More news on: Corindus Vascular Robotics, Inc., Earnings news and commentary, Consumer stocks news, Read more ...

Corindus announced today a definitive agreement to be acquired by Siemens Healthineers for approximately $1.1 billion, or $4.28 per share, in an all-cash transaction Second quarter revenue of $4.6 million reflects increasing adoption and utilization in U.S. and abroad Corindus ...

-- Corindus Stockholders to Receive $4.28 Per Share -- -- All-Cash Transaction Valued at Approximately $1.1 Billion -- Corindus Vascular Robotics (NYSE American: CVRS), a leading developer of precision vascular robotics, today announced that it has entered into a definitive...

Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that Mark Toland, President and Chief Executive Officer, and David Long, Chief Financial Officer, will present at the Canaccord Genuity 39 th Annual Growth Conference a...

Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it will release second quarter 2019 financial and business results on Thursday, August 8, 2019 before the open of the U.S. financial markets. Mark Toland, Presi...

Corindus Vascular Robotics ( CVRS ) is a producer of a vascular robotic system called CorPath, a robotic system consisting of an arm loaded with a disposable cassette that holds instruments (guidewire, balloon/stent) used in PCI (Percutaneous Coronary Intervention) procedures and a station whe...

One of the nation’s largest hospital networks adopts vascular robotic technology in multiple hospital locations to treat patients in need of cardiovascular care Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), ...

Francesca's Holdings (NASDAQ: FRAN ) +58% . More news on: Francesca's Holdings Corporation, Yatra Online, Inc., Vislink Technologies, Inc., Stocks on the move, Read more ...

Corindus Vascular Robotics (NYSEMKT: CVRS ) has received approval from the Australian Therapeutic Goods Administration to commercialize its CorPath GRX System for neurovascular interventions in Australia and New Zealand. More news on: Corindus Vascular Robotics, Inc., Healthcare sto...

Expanded indication provides access to robotic technology in vascular procedures from head to toe Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that it received approval from the Australian Therapeutic Goods ...